DE1435741U - - Google Patents

Info

Publication number
DE1435741U
DE1435741U DENDAT1435741D DE1435741DU DE1435741U DE 1435741 U DE1435741 U DE 1435741U DE NDAT1435741 D DENDAT1435741 D DE NDAT1435741D DE 1435741D U DE1435741D U DE 1435741DU DE 1435741 U DE1435741 U DE 1435741U
Authority
DE
Germany
Prior art keywords
zipfel
mtt
zitfwl
z1phl
yeneja1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1435741D
Other languages
German (de)
English (en)
Publication of DE1435741U publication Critical patent/DE1435741U/de
Active legal-status Critical Current

Links

Landscapes

  • Polyamides (AREA)
DENDAT1435741D Active DE1435741U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1435741U true DE1435741U (enrdf_load_stackoverflow)

Family

ID=744506

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1435741D Active DE1435741U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1435741U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
Mackay et al. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling
Weisz Acidification and protein traffic
Primus et al. GABAA receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure
Bernard et al. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
Low et al. The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells
White et al. The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx
Rothman et al. Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin: further evidence for two μ-binding sites
Sklar et al. Signal transduction and ligand-receptor dynamics in the human neutrophil. Transient responses and occupancy-response relations at the formyl peptide receptor.
AU713713C (en) Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
Tarozzo et al. Fractalkine protein localization and gene expression in mouse brain
Kalivas Recent understanding in the mechanisms of addiction
Lucas et al. Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons
Goldberg et al. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Tricklebank et al. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine
US6645774B1 (en) Methods of modifying feeding behavior using compounds with afinity for the human hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
DE1435741U (enrdf_load_stackoverflow)
Coldwell et al. Pharmacological characterization of extracellular acidification rate responses in human D2 (long), D3 and D4. 4 receptors expressed in Chinese hamster ovary cells
Strange Dopamine receptors: structure and function
US7303896B2 (en) Nucleic acid encoding novel type-1 cytokine receptor GLM-R
Presti et al. Receptor antagonists for gastrointestinal peptides
Gesek Alpha 2-adrenergic receptors activate phospholipase C in renal epithelial cells.
Hill et al. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein
Mori-Okamoto et al. Subtypes of adrenergic receptors and intracellular mechanisms involved in modulatory effects of noradrenaline on glutamate
Han et al. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor.
Lewis et al. Receptor-mediated folate uptake is positively regulated by disruption of the actin cytoskeleton